Working… Menu
Trial record 1 of 5 for:    Vir Biotechnology | United States
Previous Study | Return to List | Next Study

VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04725877
Recruitment Status : Recruiting
First Posted : January 27, 2021
Last Update Posted : June 11, 2021
Bill and Melinda Gates Foundation
Information provided by (Responsible Party):
Vir Biotechnology, Inc.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : October 2022
Estimated Study Completion Date : December 2024